HEY1

(redirected from CHF2)

HEY1

A gene on chromosome 8q21 that encodes a DNA-binding basic helix-loop-helix (bHLH) transcription factor. HEY1 is a downstream effector of Notch signalling and may be required for cardiovascular development by downregulating the cardiac transcriptional activators GATA4 and GATA6. It is expressed in the mesoderm, CNS, kidneys, heart, nasal epithelium and limbs, and it interacts with HES1, HEYL, HDAC1, NCOR1, SIN3A, GATA4, GATA6 and CCDC89/BOIP.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
M2 PHARMA-September 3, 2019-Strekin AG raises CHF2.82m from Series A financing round
Global Banking News-September 3, 2019-Strekin AG raises CHF2.82m from Series A financing round
M2 EQUITYBITES-September 3, 2019-Strekin AG raises CHF2.82m from Series A financing round
The agreement also consists of an earn-out element being realised until the end of March 2022, which at target is CHF2.85m, depending on performance.
The financial services firm has posted a full-year net profit of CHF2.1bn for 2018.
UBS's reported pre-tax profit of CHF2 billion was 17% higher yoy.
For 2013, the company reported a turnover of CHF2.1bn and adjusted EBITDA of CHF156m.
Both men have paid compensation and Fifa, who were being investigated for "disloyal management", also agreed to pay CHF2.5m.
According to Suleiman, the bank's assets under management (AUM) have grown to around CHF2 billion
During the first quarter of 2011 pre-tax income reached CHF2.2bn, net income was CHF1.6bn, on net revenue of CHF 8.4bn and return on equity of 18.8 percent.
The bank expects wider first quarter losses of CHF2 billion from its CHF3.9 billion write-downs and increase 0.6 percent of about 10.6 percent its capital for the said quarter.